Oramed Pharmaceuticals (ORMP) Return on Sales (2016 - 2025)

Oramed Pharmaceuticals' Return on Sales history runs 8 years deep, the most recent figure standing at 0.38% for Q4 2025.

• Quarterly Return on Sales changed N/A year-over-year to 0.38% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.38% (changed N/A YoY) and the FY2025 annual result came in at 0.38%, changed N/A from the prior year.
• Return on Sales was 0.38% for Q4 2025 at Oramed Pharmaceuticals, up from 0.22% in the prior quarter.
• Across five years, Return on Sales topped out at 0.38% in Q4 2025 and bottomed at 0.18% in Q2 2022.
• A 4-year average of 0.03% and a median of 0.09% in 2021 frame the typical range for Return on Sales.
• Peak annual rise in Return on Sales reached 17 bps in 2023, while the deepest fall reached 2 bps in 2023.
• Oramed Pharmaceuticals' Return on Sales stood at 0.09% in 2021, then sank by 57 bps to 0.13% in 2022, then jumped by 128 bps to 0.04% in 2023, then soared by 892 bps to 0.38% in 2025.
• Business Quant data shows ORMP's Return on Sales at 0.38% in Q4 2025, 0.22% in Q3 2025, and 0.12% in Q2 2025.